[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 25, Issue 1 (4-2023) ::
2023, 25(1): 65-77 Back to browse issues page
Alzheimer and its Underlying Factors in Patients with Polycystic Ovary Syndrome: A Narrative Review
M Noroozzadeh , M Amiri , F Ramezani Tehrani
Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran , fah.tehrani@gmail.com
Abstract:   (305 Views)
Alzheimer's disease (AD), a progressive neurodegenerative disease, is the most common type of dementia. Polycystic ovary syndrome (PCOS) is associated with metabolic and hormonal disorders, obesity, inflammation, gut microbiota dysbiosis, and an elevated risk of mood disorders and depression. Therefore, patients with this syndrome may be exposed to cognitive and memory disorders, followed by AD. The aim of this review was to focus on the cognitive function, memory, and the risk of dementia and AD in women with PCOS and to identify the factors affecting the risk of progression to these complications in women with this syndrome. Reviewing the literature on the relationship between PCOS and the occurrence of cognitive and memory disorders showed that several disorders linked with PCOS and some drugs used to treat these patients could positively or negatively affect the risk of the development of cognitive and memory disorders. While some reports have declared positive effects for androgens and oral contraceptive drugs on cognitive function and memory, others have argued that insulin resistance, obesity, inflammation, oxidative stress, gut microbiota dysbiosis, and depression may negatively affect cognitive and memory function in women with PCOS, predisposing them to AD. More studies are needed to estimate the risk of cognitive disorders, memory deficits, and AD in women with PCOS and to identify the factors involved in the development of these disorders. The early identification of PCOS patients at risk of developing these cognitive disorders can help prevent the progression of these conditions and appropriately treat them.
Keywords: Polycystic ovary syndrome, Cognition, Memory, Alzheimer’s disease, Dementia
Full-Text [PDF 921 kb]   (154 Downloads)    
Type of Study: Review | Subject: Endocrinology
Received: 2023/04/26 | Accepted: 2023/07/24 | Published: 2023/04/30
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Noroozzadeh M, Amiri M, Ramezani Tehrani F. Alzheimer and its Underlying Factors in Patients with Polycystic Ovary Syndrome: A Narrative Review. Iranian Journal of Endocrinology and Metabolism 2023; 25 (1) :65-77
URL: http://ijem.sbmu.ac.ir/article-1-3080-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 1 (4-2023) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645